Bionetix, ProQinase, and MercachemSyncom have announced that they will jointly develop a new AML drug, from...
Up To Date
Latest News
Merck KGaA’s 2017 Swiss cancer spin-out iOnctura SA has raised €15m to bring its PI3Kδ inhibitor and autotaxin...
Ministers from 72 countries came together at the Berlin Agriculture Ministers’ conference to discuss and adopt...
HepaRegeniX has raised €11m in a Series B. The biotech company will use the proceeds to bring its compound...
Swiss food giant Nestlé will invest up to €1.68bn to support sustainable packaging solutions and to create a...
mRNA cancer neoantigen specialist BioNTech AG is set to buy all shares of Neon Therapeutics, Inc. expanding...
Share
